Cargando…
Universal tumor-reactive helper peptides from telomerase as new tools for anticancer vaccination
Accumulating evidence demonstrates the importance of CD4(+) T cells in antitumor immune responses. Identifying promiscuous MHC class II-binding peptides derived from relevant tumor-associated antigens that specifically target CD4(+) helper T cells in vivo represent a powerful approach to fully explo...
Autores principales: | Dosset, Magalie, Vauchy, Charline, Beziaud, Laurent, Adotevi, Olivier, Godet, Yann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661170/ https://www.ncbi.nlm.nih.gov/pubmed/23802085 http://dx.doi.org/10.4161/onci.23430 |
Ejemplares similares
-
Is preexisting antitumor CD4 T cell response indispensable for the chemotherapy induced immune regression of cancer?
por: Godet, Yann, et al.
Publicado: (2012) -
Immunogenicity Evaluation of a Rationally Designed Polytope Construct Encoding HLA-A*0201 Restricted Epitopes Derived from Leishmania major Related Proteins in HLA-A2/DR1 Transgenic Mice: Steps toward Polytope Vaccine
por: Seyed, Negar, et al.
Publicado: (2014) -
Interest of Tumor-Specific CD4 T Helper 1 Cells for Therapeutic Anticancer Vaccine
por: Galaine, Jeanne, et al.
Publicado: (2015) -
Importance of helper T-cell activation in dendritic cell-based anticancer immunotherapy
por: Schreibelt, Gerty, et al.
Publicado: (2013) -
Peptide-based anticancer vaccines: The making and unmaking of a T-cell graveyard
por: Hailemichael, Yared, et al.
Publicado: (2013)